Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-17,400
Closed -$9.21M 5569
2021
Q4
$9.21M Buy
+17,400
New +$8.35M 0.01% 1735
2021
Q3
Sell
-11,600
Closed -$5.5M 4985
2021
Q2
$5.5M Hold
11,600
﹤0.01% 1954
2021
Q1
$5.33M Buy
+11,600
New +$5.69M 0.01% 1790
2020
Q2
Sell
-4,100
Closed -$1.78M 4010
2020
Q1
$1.78M Sell
4,100
-4,000
-49% -$1.79M ﹤0.01% 2263
2019
Q4
$3.56M Buy
8,100
+4,100
+103% +$1.72M ﹤0.01% 2011
2019
Q3
$1.67M Buy
+4,000
New +$1.63M ﹤0.01% 2494
2018
Q4
Sell
-2,800
Closed -$895K 3775
2018
Q3
$895K Sell
2,800
-15,000
-84% -$4.78M ﹤0.01% 2760
2018
Q2
$5.73M Buy
+17,800
New +$5.57M 0.01% 1436
2013
Q3
Sell
-3,000
Closed -$217K 4301
2013
Q2
$217K Buy
+3,000
New +$220K ﹤0.01% 3722

Other funds holding CHE

David Shaw's CHE Position: Q2 2026 in Review

David Shaw reduced its Chemed (CHE) stake by 86% in Q2 2026, selling an estimated $15.5M and leaving 6,160 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

David Shaw first reported a position in CHE in Q3 2014 and has held it in 37 quarters since. The position peaked at $36.9M in Q2 2018. 528 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • David Shaw held 6,160 shares of Chemed worth $2.87M as of Q2 2026.
  • David Shaw sold 36,749 Chemed shares in Q2 2026, an estimated $15.5M.
  • Chemed made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2894 holding.
  • David Shaw first reported a position in Chemed in Q3 2014 and has held it in 37 quarters since.
  • David Shaw's Chemed position peaked at $36.9M in Q2 2018.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.